BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10695510)

  • 1. Prevention of restenosis after percutaneous coronary interventions: the medical approach.
    Rosanio S; Tocchi M; Patterson C; Runge MS
    Thromb Haemost; 1999 Sep; 82 Suppl 1():164-70. PubMed ID: 10695510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
    Nikol S; Höfling B
    Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restenosis and arterial remodelling after coronary angioplasty].
    Jørgensen B; Forfang K
    Tidsskr Nor Laegeforen; 1996 Aug; 116(20):2460-3. PubMed ID: 8928109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy of restenosis].
    Steg PG; Feldman L
    Pathol Biol (Paris); 1998 Mar; 46(3):201-4. PubMed ID: 9769916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-eluting stents do they make the difference? ].
    Presbitero P; Asioli M
    Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
    Gidlöf AC; Ocaya P; Krivospitskaya O; Sirsjö A
    Clin Sci (Lond); 2008 Jan; 114(1):19-25. PubMed ID: 18047466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation.
    Nikol S; Huehns TY; Krausz E; Armeanu S; Engelmann MG; Winder D; Salmons B; Hoefling B
    Gene Ther; 1999 May; 6(5):737-48. PubMed ID: 10505096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
    Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing restenosis after angioplasty: a multistage approach.
    Zargham R
    Clin Sci (Lond); 2008 Feb; 114(4):257-64. PubMed ID: 18194134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-intervention vessel remodeling.
    Rutanen J; Puhakka H; Ylä-Herttuala S
    Gene Ther; 2002 Nov; 9(22):1487-91. PubMed ID: 12407420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
    Kipshidze N; Dangas G; Tsapenko M; Moses J; Leon MB; Kutryk M; Serruys P
    J Am Coll Cardiol; 2004 Aug; 44(4):733-9. PubMed ID: 15312851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospects of prevention of restenosis after coronary angioplasty].
    Le Feuvre C; Tahlil O; Feldman LJ; Steg PG
    Ann Cardiol Angeiol (Paris); 1996; 45(7):383-8. PubMed ID: 8952733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on antisense therapy for the prevention of restenosis.
    Kipshidze N; Moses J; Shankar LR; Leon M
    Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease.
    Degertekin M; Regar E; Tanabe K; Lee CH; Serruys PW
    Minerva Cardioangiol; 2002 Oct; 50(5):405-18. PubMed ID: 12384623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standards in interventional therapy of coronary artery disease].
    Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G
    Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
    Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
    Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of locally delivered conventional drug therapies.
    Camenzind E; Kutryk MJ; Serruys PW
    Semin Interv Cardiol; 1996 Mar; 1(1):67-76. PubMed ID: 9552496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.